NextPoint Therapeutics, Inc.
Lisa M. is a seasoned professional in program and clinical operations management, currently serving as Director of Program Management at NextPoint Therapeutics, Inc. since August 2022. Prior to this, Lisa M. held various leadership roles at GSK from October 2019 to August 2022, including Associate Director of Scientific Operations in R&D Oncology, where contributions to the niraparib (ZEJULA) program earned recognition through multiple employee awards. Lisa M. has significant experience in clinical operations, having previously worked at TESARO, Inc. and Biobusiness Consulting Incorporated, among others. Educational credentials include a Master's degree and significant coursework in Epidemiology & Evidence Based Medicine from the University of Pennsylvania and a Bachelor’s degree in Human Physiology and Biological Sciences from West Chester University of Pennsylvania.
This person is not in the org chart
This person is not in any teams
NextPoint Therapeutics, Inc.
NextPoint Therapeutics develops medications to expand the benefit of immunotherapies to cancer patients. The company offers immunotherapies for a validated checkpoint axis that is independent of PD-1/L1 and modulates both adaptive and innate immune systems to find and destroy cancer cells.